Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (210)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Baird, A.
Right arrow Articles by Walicke, P. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baird, A.
Right arrow Articles by Walicke, P. A
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 45:438-452 (1989)
© 1989 The British Council

research-article

Fibroblast growth factors

Andrew Baird1 and Patricia A Walicke2

1Laboratories for Neuroendocrinology, Salk Institute La Jolla, California, USA
2Department of Neuroscience, University of California at San Diego La Jolla, California, USA

Abstract

The existence of fibroblast growth factors (FGFs) was proposed over 40 years ago to account for the ability of tissue extracts to stimulate fibroblast proliferation In the 1970s it became clear that preparations containing FGF activity were in fact pleiotropic, affecting the growth and function of a wide variety of mesenchymal, endocrine and neural cells. Their angiogenic effects have promoted research in cardiology and neurology because of their proposed role in stimulating collateral vascularisation and recovery from ischemia. Their identity with a component of tumour angiogenesis factor activity has stimulated research in oncology and their capacity to enhance wound healing, nerve regeneration and cartilage repair has affected research in neurology, orthopaedic medicine and pathology. The potential therapeutic value of FGFs is just beginning to be realized and will be dependent on a concerted effort to establish their function in the regulation of normal cell homeostais and the pathophysiology of disease.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. K. Jones, R. M. Itani, H. Wang, M. Tomikawa, I. J. Sarfeh, S. Szabo, and A. S. Tarnawski
Activation of VEGF and Ras genes in gastric mucosa during angiogenic response to ethanol injury
Am J Physiol Gastrointest Liver Physiol, June 1, 1999; 276(6): G1345 - G1355.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. J. Dowd, C. L. Cooney, and M. A. Nugent
Heparan Sulfate Mediates bFGF Transport through Basement Membrane by Diffusion with Rapid Reversible Binding
J. Biol. Chem., February 19, 1999; 274(8): 5236 - 5244.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
T. Yoshimoto, K. Houkin, A. Takahashi, and H. Abe
Angiogenic Factors in Moyamoya Disease
Stroke, December 1, 1996; 27(12): 2160 - 2165.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
W. Schaper and W. D. Ito
Molecular Mechanisms of Coronary Collateral Vessel Growth
Circ. Res., November 1, 1996; 79(5): 911 - 919.
[Full Text]

Home page
 DevelopmentHome page
Y. Kinoshita, C. Kinoshita, J. G. Heuer, and M. Bothwell
Basic fibroblast growth factor promotes adhesive interactions of neuroepithelial cells from chick neural tube with extracellular matrix proteins in culture
Development, November 1, 1993; 119(3): 943 - 956.
[Abstract] [PDF]

Home page
 PERSPECT VASC SURG ENDOVASC THERHome page
D. A. Bull, G. C. Hunter, and C. W Putnam
Growth Factors and the Arterial Wall: Implications for Vessel Repair, Atherosclerosis, and Intimal Hyperplasia
Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1991; 4(2): 87 - 103.
[PDF]

Home page
 ScienceHome page
R. Kaner, A Baird, A Mansukhani, C Basilico, B. Summers, R. Florkiewicz, and D. Hajjar
Fibroblast growth factor receptor is a portal of cellular entry for herpes simplex virus type 1
Science, June 15, 1990; 248(4961): 1410 - 1413.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.